COMPUTATIONAL IDENTIFICATION OF IMMUNOMODULATORY NATURAL COMPOUNDS AS POTENTIAL MULTI-TARGET INHIBITORS OF SARS-COV-2 PROTEINS: MOLECULAR DOCKING, PHARMACOKINETIC AND ACUTE TOXICITY PROFILING
Journal of Medical & Health Sciences Review · 30.03.2026 · 3 (1) · 359-367
DOI: 10.65035/mjq2j733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical & Health Sciences Review, online erschienen am 30.03.2026. Verfasst von Sania und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the COVID-19 pandemic. Vaccines reduced disease severity, but effective and broadly applicable therapeutics remain limited, and many repurposed drugs showed modest efficacy or adverse effects. Immunomodulatory compounds are attractive because they may act on viral proteins and on the dysregulated host immune response at the same time.
Methods
A library of 584 medicinal immunomodulatory compounds was virtually screened with AutoDock Vina through the Raccoon2 interface against five SARS-CoV-2 targets: the SARS coronavirus main peptidase (PDB 2GTB), the main protease Mpro (6LU7), the spike glycoprotein (6VSB), NSP-15 endoribonuclease (6VWW) and the NSP-9 replicase protein (6W4B). Receptors were refined with ModRefiner, active sites were predicted with MetaPocket 2.0, and ligands were prepared with the PRODRG server. Compounds forming hydrogen bonds with active-site residues were retained, and pose stability was evaluated with LigRMSD. Acute rat toxicity and OECD classification were predicted with GUSAR, and pharmacokinetic and drug-likeness properties with SwissADME.
Results
Six compounds (arzanol, ferulic acid, genistein, resveratrol, rosmanol and thymohydroquinone) formed hydrogen bonds with active-site residues of the viral targets. Binding affinities ranged from −4.7 to −7.0 kcal/mol, with arzanol (−7.0 kcal/mol against 2GTB and 6VWW) and rosmanol (−6.7 kcal/mol against 6LU7 and 6VSB) among the strongest and genistein strongest against 6W4B (−6.9 kcal/mol). Ligand RMSD values were 0.35–1.53 Å. All six compounds were predicted to have high gastrointestinal absorption and no Lipinski violations. Predicted oral LD50 values in rats corresponded to OECD Class 4 (arzanol, genistein, rosmanol, thymohydroquinone) or Class 5 (ferulic acid, resveratrol).
Conclusion
These natural immunomodulators combine multi-target binding, favourable predicted pharmacokinetics and low predicted acute toxicity, making them candidates for in vitro, in vivo and clinical evaluation. Because docking affinities are moderate and all findings are in silico, experimental validation is essential.
Zitieren
APA
Sania, Shehzai, K., Bibi, M., Ali, R., Sultan, A., Khan, M. R., Fawad, N., & Ali, S. (2026). COMPUTATIONAL IDENTIFICATION OF IMMUNOMODULATORY NATURAL COMPOUNDS AS POTENTIAL MULTI-TARGET INHIBITORS OF SARS-COV-2 PROTEINS: MOLECULAR DOCKING, PHARMACOKINETIC AND ACUTE TOXICITY PROFILING. Journal of Medical & Health Sciences Review, 3(1), 359-367. https://doi.org/10.65035/mjq2j733
Vancouver
Sania, Shehzai K, Bibi M, Ali R, Sultan A, Khan MR, et al. COMPUTATIONAL IDENTIFICATION OF IMMUNOMODULATORY NATURAL COMPOUNDS AS POTENTIAL MULTI-TARGET INHIBITORS OF SARS-COV-2 PROTEINS: MOLECULAR DOCKING, PHARMACOKINETIC AND ACUTE TOXICITY PROFILING. Journal of Medical & Health Sciences Review. 2026;3(1):359-367. doi:10.65035/mjq2j733
BibTeX
@article{Sania2026,
author = {Sania and Shehzai, Kiran and Bibi, Maryam and Ali, Rukhsar and Sultan, Amna and Khan, Muhammad Raees and Fawad, Nida and Ali, Sana},
title = {COMPUTATIONAL IDENTIFICATION OF IMMUNOMODULATORY NATURAL COMPOUNDS AS POTENTIAL MULTI-TARGET INHIBITORS OF SARS-COV-2 PROTEINS: MOLECULAR DOCKING, PHARMACOKINETIC AND ACUTE TOXICITY PROFILING},
journal = {Journal of Medical & Health Sciences Review},
year = {2026},
volume = {3},
number = {1},
pages = {359--367},
doi = {10.65035/mjq2j733}
}
EUVIMED